The Protective Effects of Probiotic-Fermented Soymilk on High-Fat Diet-Induced Hyperlipidemia

Yuhua Wang,Chunhong Piao,Junmei Liu,Hansong Yu,Weichang Dai,Xiujuan Wang
DOI: https://doi.org/10.1096/fasebj.31.1_supplement.646.26
2017-01-01
Abstract:T he effects of probiotic mixture (Bifidobacterium bifidum , Lactobacillus casei and L. plantarum)‐fermented soymilk on high‐fat diet (HFD)‐induced hyperlipidemia and liver injury were explored. C57BL/6N mice were randomly assigned into four groups treated with different diets: Normal chow (NC); HFD; HFD with probiotic‐fermented soymilk; HFD with non‐fermented soymilk. After treatment for 6 weeks, probiotic‐fermented soymilk treatment significantly reduced HFD‐induced body weight gain, hyperlipidemia, liver fat accumulation and reactive oxygen species (ROS) production. In addition, probiotic‐fermented soymilk consumption resulted in significant reduction in serum alanine aminotransferase (ALT), lipopolysaccharide (LPS) and liver tumor necrosis factor‐α (TNF‐α) levels compared with HFD treatment. Further, probiotic‐fermented soymilk significantly increased the serum leptin level. In conclusion, probiotic‐fermented soymilk had a function of reducing hyperlipidemia and liver injury induced by HFD. The role of probiotic‐fermented soymilk may involve decreasing the production of liver LPS, TNF‐α and oxidative stress and inducing adipose leptin and triacylglycerol hydrolase (TGH) production. Support or Funding Information This work was partly supported by Ministry of Science and Technology, People's Republic of China, for providing financial support (2013BAD18B07).
What problem does this paper attempt to address?